Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The casual dining industry has been on the brink of destruction for a long time. Now, many in the sector are starting to fall off the edge.
Novo Nordisk scored approval to sell its Wegovy weight loss drug in China. That’s a big win, but competitors will soon flood in.
As the frequency of cyberattacks on healthcare systems and hospitals increases, so too do the costs for preventing them.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
With oil in decline, Masdar, the United Arab Emirates state-backed renewables company, is on an acquisition shopping spree.
Big Tech loves movies, TV shows, and live sports. So why has it shown remarkably little appetite for the TV news business?
You’d think the biggest election year in history would be good news for pollsters. In the case of YouGov, you’d be wrong.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Fisker, the electric vehicle startup, filed for Chapter 11 bankruptcy Tuesday. The real surprise is that it stuck around as long as it did.
A patent from Honda seeks to make EV charging cheaper and better for the environment.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.